D2C Nutrition Brand Funding: Is Ace Blend’s $9.9M Proven Success?
D2C nutrition brand funding is on the rise. Ace Blend’s recent $9.9M Series A2 round highlights significant investor interest.
US IPO news: Is ADARx Pharmaceuticals’ $446.3M Raise Worth It?
US IPO news reveals ADARx Pharmaceuticals raised $446.3 million in an upsized offering, showcasing strong investor interest.